{
  "report_rows": [
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.29 vs. cons $2.24",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.4% vs. cons 3.15%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~24.8% vs. cons 24.65%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.70 midpoint vs. cons $8.70 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted organic sales growth guidance",
      "prediction": "LOWER",
      "answer": "guide ~3.0% vs. cons 3.1% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating-margin expansion guidance",
      "prediction": "BETTER",
      "answer": "guide ~85 bps midpoint vs. cons 80 bps (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "The predicted Q2 EPS beat of ~$0.05 ($2.29 vs. $2.24) is absorbed by FY2026 guidance of ~$8.70 vs. consensus $8.70, implying second-half EPS of ~$4.27 vs. the pre-report implied ~$4.32. That ~$0.05 out-period cut should limit revisions and cause the initial organic-growth and margin relief rally to fade.",
  "day5_confidence": "MEDIUM"
}